Seventy-two iGAS outbreaks in LTCFs were identified, from individual outbreak reports (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) or summary data identified in surveillance studies or reviews (6, 13, (15) (16) (17) (18) (19) (20) , or laboratory studies (16) . These 72 include 31 clusters defined as outbreaks based on shared subtypes among 2 or more cases occurring at a facility within 1 year (15, 18) . One of these found 13 clusters which shared sub-type, institution and time period among 134 cases, and eight instances of two isolates from the same time period and institution but with distinguishable subtypes which did not meet their subtype based outbreak definition. Among outbreaks identified by other means 22 reported subtyping. Nineteen of these identified a single or dominant strain (1, 3, (5) (6) (7) (8) (9) (10) (11) (12) (13) 16) , and three multiple strains (2, 4, 14) .
Treatment restricted to those ill or to cases and direct contacts of cases with laboratory confirmed infection was associated with control in some outbreaks (5, 7, 13) , although in one mass chemoprophylaxis was applied following recurrence after two rounds of this selective treatment (1) . Screening all staff and residents with chemoprophylaxis if positive (2) (3) (4) 6, 8, 9, (11) (12) (13) (14) was associated with recurrence and repeated screening and treatment in two reports (2, 8) . Further cases of iGAS were diagnosed between decisions to screen and chemoprophylax and the implementation of chemoprophylaxis (1, 11) . Mass chemoprophylaxis of all staff and residents was associated with control of iGAS (1, 3, 10, 13) although in one incident persistent infection was shown in one resident with a gastrostomy tube (1) . Screening detected carriage rates were below 10% among residents with two exceptions (20% (5) and 16% (11)) with lower rates among staff than residents as reviewed elsewhere (6, 13) . 
